Login
From:
The Hub
(Uncensored)
subscribe
FDA approves drug for treatment of rare mitochondrial disorder | Hub
https://hub.jhu.edu/2025/09/25/fda-approves-barth-syndrome-treatment/
links
backlinks
First-of-its-kind therapy developed by Johns Hopkins researchers cleared for treatment of Barth syndrome, a condition that causes muscle weakness, an enlarged heart, and shortened life expectancy
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
